Stany Zjednoczone - angielski - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide capsules, usp is indicated for the treatment of adult patients with newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. temozolomide capsules, usp is indicated for the treatment of adult patients with refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine. temozolomide capsules, usp is contraindicated in patients with a history of hypersensitivity reactions to: - temozolomide or any other ingredients in temozolomide capsules, usp; and - dacarbazine, since both temozolomide and dacarbazine are metabolized to the same active metabolite 5-(3­-methyltriazen-1-yl)-imidazole-4-carboxamide. reactions to temozolomide have included anaphylaxis [see adverse reactions (6.2)]. risk summary based on its mechanism of action [see clinical pharmacology (12.1)] and findings from animal studies, temozolomide can cause fetal harm when administered to a pregnant woman. available postmarke

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine. temozolomide is contraindicated in patients with a history of hypersensitivity reactions to: - temozolomide or any other ingredients in temozolomide capsules; and - dacarbazine, since both temozolomide and dacarbazine are metabolized to the same active metabolite 5-(3-methyltriazen-1-yl)-imidazole-4-carboxamide. reactions to temozolomide have included anaphylaxis [see adverse reactions (6.2)]. risk summary based on its mechanism of action [see clinical pharmacology (12.1)] and findings from animal studies, temozolomide can cause fetal harm when administered to a pregnant woman. available postmarketing reports describe cases of spon

Kanada - angielski - Health Canada

accord healthcare inc - temozolomide - capsule - 20mg - temozolomide 20mg - antineoplastic agents

Kanada - angielski - Health Canada

accord healthcare inc - temozolomide - capsule - 100mg - temozolomide 100mg - antineoplastic agents

Kanada - angielski - Health Canada

accord healthcare inc - temozolomide - capsule - 140mg - temozolomide 140mg - antineoplastic agents

Kanada - angielski - Health Canada

accord healthcare inc - temozolomide - capsule - 180mg - temozolomide 180mg - antineoplastic agents

Kanada - angielski - Health Canada

accord healthcare inc - temozolomide - capsule - 250mg - temozolomide 250mg - antineoplastic agents

Kanada - angielski - Health Canada

teva canada limited - temozolomide - capsule - 20mg - temozolomide 20mg - antineoplastic agents

Kanada - angielski - Health Canada

teva canada limited - temozolomide - capsule - 100mg - temozolomide 100mg - antineoplastic agents

Kanada - angielski - Health Canada

teva canada limited - temozolomide - capsule - 140mg - temozolomide 140mg - antineoplastic agents